APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 148 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 3.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $3,312,000 | -11.1% | 73,232 | -0.1% | 0.03% | +3.4% |
Q1 2022 | $3,727,000 | +7.6% | 73,340 | +0.1% | 0.03% | +11.5% |
Q4 2021 | $3,463,000 | -28.0% | 73,242 | -49.8% | 0.03% | -16.1% |
Q3 2021 | $4,808,000 | +6.8% | 145,868 | +104.9% | 0.03% | -20.5% |
Q2 2021 | $4,500,000 | +47.4% | 71,195 | +0.1% | 0.04% | +34.5% |
Q1 2021 | $3,052,000 | -24.9% | 71,127 | +0.1% | 0.03% | -31.0% |
Q4 2020 | $4,066,000 | +76.6% | 71,090 | +0.8% | 0.04% | +40.0% |
Q3 2020 | $2,303,000 | -1.3% | 70,525 | -1.3% | 0.03% | -6.2% |
Q2 2020 | $2,334,000 | +22.0% | 71,481 | +0.1% | 0.03% | -8.6% |
Q1 2020 | $1,913,000 | -15.4% | 71,396 | -3.2% | 0.04% | 0.0% |
Q4 2019 | $2,260,000 | +2.4% | 73,783 | -16.0% | 0.04% | +2.9% |
Q3 2019 | $2,208,000 | +104.3% | 87,879 | +106.0% | 0.03% | +70.0% |
Q2 2019 | $1,081,000 | +478.1% | 42,650 | +201.4% | 0.02% | +300.0% |
Q4 2018 | $187,000 | – | 14,150 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AJU IB Investment Co., Ltd. | 624,962 | $20,599,000 | 13.29% |
Octagon Capital Advisors LP | 1,595,911 | $52,601,000 | 12.95% |
Logos Global Management LP | 1,450,000 | $47,792,000 | 3.45% |
Avoro Capital Advisors LLC | 5,000,000 | $164,800,000 | 2.59% |
Ghost Tree Capital, LLC | 200,000 | $6,592,000 | 1.93% |
Integral Health Asset Management, LLC | 190,000 | $6,262,000 | 1.80% |
GREAT POINT PARTNERS LLC | 200,000 | $6,592,000 | 1.54% |
Aufman Associates Inc | 53,642 | $1,768,000 | 1.45% |
Ghost Tree Capital, LLC | 150,000 | $4,944,000 | 1.45% |
Altium Capital Management LP | 166,700 | $5,494,000 | 1.44% |